In accordance with the above studies on the anti-inflammatory and antioxidant effects of vitamin D on the serum levels of vitamin D, inflammatory factors, and TAC in the treatment of cancer and due to the effect of increasing TNF-α and TGF-β1 [43, 44] and decreasing serum levels of TAC [45] and vitamin D in the progression of breast cancer, using the methods that can predict these effects accelerate the healing process and reduce mortality [34, 46]. The gene discussed is TGFB1; the disease is breast carcinoma.